Innovation boosts bio-tech company's growth
China DailyShandong BellaGen Biotechnology Co, a high-tech company based in Jinan, capital of East China's Shandong province, is a national leader in developing cutting-edge gene-editing technology. It is the first Chinese company to independently develop CRISPR Cas SF01 and CRISPR Cas SF02 core gene-editing technologies. BellaGen Biotechnology has built a world-class research and development platform for gene editing, established a platform for biological breeding and formed an innovation system integrating gene editing and cutting-edging technologies. According to Li Guofu, deputy general manager of BellaGen, the company has cultivated over 20 new high-yield crop varieties, including high-yield rice and high-oleic soybeans, which have obtained the necessary certificates for industrial production.